Cognitive and emotional predictors of quality of life and functioning after COVID‐19

• Published in: Annals of clinical and translational neurology Vol. 11; no. 2; pp. 302 - 320
• Main Authors: Ariza, Mar, Cano, Neus, Segura, Bàrbara, Bejar, Javier, Barrué, Cristian, Bernia, Jose A., Arauzo, Vanesa, Balague‐Marmaña, Marta, Cañizares, Silvia, Muñoz, Jose Antonio Lopez, Caballero, Jesús, Carnes‐Vendrell, Anna, Piñol‐Ripoll, Gerard, Gonzalez‐Aguado, Ester, Tayó‐Juli, Carme, Forcadell‐Ferreres, Eva, Reverte‐Vilarroya, Silvia, Forné, Susanna, Muñoz‐Padros, Jordina, Bartes‐Plan, Anna, Muñoz‐Moreno, Jose A., Prats‐Paris, Anna, Gasa‐Roqué, Anna, Valls, Laura Casas, Almeria, Marta, Castejon, Judith, Ciudad, Maria José, Ferré, Anna, Lozano, Manuela, Garzon, Tamar, Cullell, Marta, Vega, Sonia, Alsina, Sílvia, Maldonado‐Belmonte, Maria J., Vazquez‐Rivera, Susana, García‐Cabello, Eloy, Molina, Yaiza, Navarro, Sandra, Baillès, Eva, Cortés, Claudio Ulises, Junqué, Carme, Garolera, Maite
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01.02.2024; John Wiley and Sons Inc; Wiley
• Subjects: Anxiety; Cognitive ability; COVID-19; Disease; Executive function; Health facilities; Hospitalization; Hospitals; Infections; Neurodevelopmental disorders; Neuropsychology; Patients; Population; Quality of life; Severe acute respiratory syndrome coronavirus 2; Andorra; Spain

Objective A long‐term decline in health‐related quality of life (HRQoL) has been reported after coronavirus disease 2019 (COVID‐19). Studies with people with persistent symptoms showed inconsistent outcomes. Cognition and emotion are important determinants in HRQoL, but few studies have examined the...